ISIN | CH0021722035 |
---|---|
Valor Number | 2172203 |
Bloomberg Global ID | BBG000QRSH49 |
Fund Name | AMC PROFESSIONAL FUND-BCV Enhanced Europe Eq. ESG -C- |
Fund Provider |
BCV
Lausanne, Switzerland Phone: +41 848 808 880 E-Mail: info@bcv.ch Web: www.bcv.ch |
Fund Provider | BCV |
Representative in Switzerland | |
Distributor(s) |
Banque Cantonale Vaudoise Lausanne Phone: +41 21 212 10 00 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Distribution |
Home Country | Switzerland |
Issuing Condition | The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets) |
Redemption Condition | The fund charges a transaction fee (contribution towards covering expenses incurred in the sale of assets) |
Investment Strategy *** | BCV Enhanced Europe Equity ESG is focused on achieving long-term capital appreciation. This broadly diversified Sub-fund is managed according to a quantitative model-based approach. This approach aims to generate a moderate and consistent outperformance of the US stock market while limiting the relative risk of the latter. The Sub-fund invests in equities and other securities including dividend-right certificates, membership shares, participation certificates, and similar instruments of companies having their registered office in geographical Europe or exercising a preponderant part of their economic activity therein. The manager invests preferably in companies with a high ESG rating. The percentage invested in collective investment schemes is limited to a maximum of 10% of the Sub-fund's assets. |
Peculiarities |
Current Price * | 157.56 EUR | 12.05.2025 |
---|---|---|
Previous Price * | 155.28 EUR | 09.05.2025 |
52 Week High * | 161.03 EUR | 03.03.2025 |
52 Week Low * | 134.44 EUR | 09.04.2025 |
NAV * | 157.56 EUR | 12.05.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 221,808,140 | |
Unit/Share Assets *** | 177,935,711 | |
Trading Information SIX |
YTD Performance | +8.18% |
31.12.2024 - 12.05.2025
31.12.2024 12.05.2025 |
---|---|---|
YTD Performance (in CHF) | +7.98% |
31.12.2024 - 12.05.2025
31.12.2024 12.05.2025 |
1 month | +9.92% |
14.04.2025 - 12.05.2025
14.04.2025 12.05.2025 |
3 months | +0.61% |
12.02.2025 - 12.05.2025
12.02.2025 12.05.2025 |
6 months | +10.22% |
12.11.2024 - 12.05.2025
12.11.2024 12.05.2025 |
1 year | +4.51% |
13.05.2024 - 12.05.2025
13.05.2024 12.05.2025 |
2 years | +20.74% |
12.05.2023 - 12.05.2025
12.05.2023 12.05.2025 |
3 years | +36.26% |
12.05.2022 - 12.05.2025
12.05.2022 12.05.2025 |
5 years | +78.27% |
12.05.2020 - 12.05.2025
12.05.2020 12.05.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
SAP SE | 3.29% | |
---|---|---|
ASML Holding NV | 3.11% | |
AstraZeneca PLC | 2.62% | |
Novo Nordisk AS Class B | 2.52% | |
HSBC Holdings PLC | 2.32% | |
Siemens AG | 1.93% | |
Lvmh Moet Hennessy Louis Vuitton SE | 1.90% | |
Allianz SE | 1.83% | |
Unilever PLC | 1.81% | |
TotalEnergies SE | 1.72% | |
Last data update | 31.03.2025 |
TER | 0.26% |
---|---|
TER date | 30.09.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.60% |
Ongoing Charges *** | 0.26% |
SRRI ***
|
|
SRRI date *** | 30.04.2025 |